PRTC
Price
$17.15
Change
-$0.10 (-0.58%)
Updated
Aug 11 closing price
Capitalization
432.2M
15 days until earnings call
XOMAO
Price
$25.17
Change
-$0.19 (-0.75%)
Updated
Aug 11, 04:28 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

PRTC vs XOMAO

Header iconPRTC vs XOMAO Comparison
Open Charts PRTC vs XOMAOBanner chart's image
PureTech Health
Price$17.15
Change-$0.10 (-0.58%)
Volume$4.92K
Capitalization432.2M
XOMA
Price$25.17
Change-$0.19 (-0.75%)
Volume$407
CapitalizationN/A
PRTC vs XOMAO Comparison Chart in %
Loading...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRTC vs. XOMAO commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a StrongBuy and XOMAO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (PRTC: $17.25 vs. XOMAO: $25.36)
Brand notoriety: PRTC and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 65% vs. XOMAO: 55%
Market capitalization -- PRTC: $432.2M vs. XOMAO: $0
PRTC [@Biotechnology] is valued at $432.2M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 0 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • PRTC’s FA Score: 0 green, 5 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAO is a better buy in the long-term than PRTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRTC’s TA Score shows that 5 TA indicator(s) are bullish while XOMAO’s TA Score has 3 bullish TA indicator(s).

  • PRTC’s TA Score: 5 bullish, 5 bearish.
  • XOMAO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PRTC is a better buy in the short-term than XOMAO.

Price Growth

PRTC (@Biotechnology) experienced а -9.63% price change this week, while XOMAO (@Biotechnology) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

PRTC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMAO YTD gains are higher at: 5.160 vs. PRTC (-6.555).
PRTCXOMAOPRTC / XOMAO
Capitalization432MN/A-
EBITDAN/AN/A-
Gain YTD-6.5555.160-127%
P/E Ratio8.17N/A-
RevenueN/AN/A-
Total CashN/A93.3M-
Total DebtN/A114M-
TECHNICAL ANALYSIS
Technical Analysis
PRTCXOMAO
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
24%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
29%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
22%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
14%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
23%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
21%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
Bullish Trend 28 days ago
22%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 15 days ago
23%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
19%
View a ticker or compare two or three
Interact to see
Advertisement
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTCX22.090.21
+0.96%
Fidelity Advisor Biotechnology C
JNVSX19.010.05
+0.26%
Jensen Quality Mid Cap J
FIJZX52.510.09
+0.17%
Fidelity Advisor Consumer Discret Z
LTAGX16.310.01
+0.06%
Lord Abbett International Growth R5
FRIFX12.17-0.03
-0.25%
Fidelity Real Estate Income

PRTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTC has been loosely correlated with IRON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTC jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
-3.90%
IRON - PRTC
34%
Loosely correlated
+1.68%
ZLAB - PRTC
31%
Poorly correlated
+2.58%
AUTL - PRTC
28%
Poorly correlated
-0.85%
MDWD - PRTC
28%
Poorly correlated
-0.80%
OABI - PRTC
27%
Poorly correlated
+4.79%
More

XOMAO and

Correlation & Price change

A.I.dvisor tells us that XOMAO and XOMAP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XOMAO and XOMAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.56%
XOMAP - XOMAO
23%
Poorly correlated
+0.59%
PBM - XOMAO
22%
Poorly correlated
-4.07%
DARE - XOMAO
21%
Poorly correlated
-5.88%
PRTC - XOMAO
21%
Poorly correlated
-3.90%
IBIO - XOMAO
20%
Poorly correlated
-0.13%
More